Embedding NCCN content and other resources into an analytics and clinical decision support platform, such as Flatiron Assist, can help cancer centers gain visibility into provider decision making – and support oncologists with detailed guidance highlighting suggested care pathways.
In a recent Becker's podcast, Rebecca Maniago, PharmD, BCOP, Associate Director of Clinical Oncology at Flatiron Health, discusses the top barriers in uptake of new cancer therapies and the role technology plays in ensuring clinicians have easy access to information on these novel therapies.
Technology should support the evolution of oncology care, not get in the way. Here’s how Flatiron Health is delivering on the promises of technology by facilitating information flow, reducing manual effort, and staying ahead of the pace of change in cancer care.
Oncology care is becoming more complex every day, offering hope to patients, but bringing challenges to clinicians who need access to the latest and most accurate data. Collaboration and shared standards are essential for ensuring that the industry can maximize the potential of precision medicine.
Many practices are wary about the new Enhancing Oncology Model (EOM). A recent panel with industry experts discusses the top considerations and implications for practices who are evaluating EOM participation.
With the introduction of the Enhancing Oncology Model, practices have much to consider. Hear from oncology leaders about the top considerations and implications for practices who are evaluating EOM participation.
In this webinar in partnership with Becker's Healthcare, three experts in the oncology industry sat down to discuss how NCCN guidelines and clinical pathways are evolving at the point of care. Key takeaways include:
The newly announced Enhancing Oncology Model will advance the transition to value-based care for oncology practices. Here are four intriguing, high-impact principles guiding the innovative program.
Hot on the heels of closing out the flagship Oncology Care Model (OCM) in June of 2022, CMS is introducing the next step in value-based care for oncology practices.
We spoke with Carmen and Manda about a typical day in the practice, their experience with the new Drug Substitution feature and more.
We spoke with Olivia Barrett about her experience with Flatiron Assist, data reporting at her practice, the Oncology Medical Home pilot program and more.
We spoke with Kailee Hawkins about time-saving OncoTrials™ features, the Prospective Clinico-Genomic study that her practice is involved in and more.
We spoke with Pamela about tips that help practice administrators, the new Genomic Profiling Integration with Foundation Medicine, upcoming OncoEMR® features and more.
We spoke with Heather about networking between different oncology practices, her experience with the revamped Visit Documentation workflow, and more.
We spoke with Vivien about the regimen workflow process at Flatiron, how OncoEMR is designed from a clinician’s point of view, and more.
We spoke with Kahiya Jackson and Kurt Campbell about situations that specifically affect smaller practices, tips that help them succeed in their role, the benefits and advantages of smaller practices and more.
We spoke with Rachel De La Rosa about her start in community oncology, the new tumor assessments feature in OncoEMR®, the experience of beta testing a new feature, and more.
This OncoCloud Virtual panel discussion spoke on the value of RWE to support regulatory decision-making and improve patient care.
Tune into this recording from OncoCloud Virtual to learn tactics and strategies from community oncology leaders that can help you grow and diversify your practice.
Watch a replay of The State of the Union from OncoCloud Virtual. This session kicked off the week, covering how to make the most of the event, sharing stories across the network, and revealing some surprises.
Precision medicine unlocks access to standard of care and experimental therapies with the promise of improving outcomes and advancing cancer care for everyone.
Watch the OncoCloud Virtual replay of this fireside chat with Dr. Robert Wachter (author of The Digital Doctor) to hear how new and complex market forces like value-based payment models, technology and artificial intelligence, and consolidation are reshaping and disrupting the healthcare industry.
Watch this OncoCloud Virtual recording to hear from experts on the value of prospective clinical research to make trials more accessible to patients.
Community oncology plays a critical role in improving clinical trial accessibility. In this panel you'll hear from clinical research leaders who are making clinical trials more accessible and inclusive, including practical takeaways for research programs.
As the oncology market waits with bated breath for the final rule from the Centers for Medicare & Medicaid Services (CMS) Center for Medicare and Medicaid Innovation (Innovation Center) around the next iteration of the Oncology Care Model (OCM) — Flatiron HC™ reflects on our value-based care tools and performance.
We spoke with Dr. Iuliana Shapira about how COVID affected her practice, the way the government gets involved in electronic health records and the advice she has for us on improving CareSpace.
We spoke with Anne Slam about the biggest challenges facing practice administrators, what it takes to keep a healthy practice running, why RCM services seem threatening and more.
We spoke with Dr. Ted Arrowsmith about the benefits of centrally managed regimens, the difference between OncoEMR® and hospital systems, the dream of robust decision support and more.
In March 2021, Flatiron hosted our Product Roadmap Webinar for customers to join and learn about upcoming OncoCloud features and products.
A guide to preparing your practice for success in value-based arrangements.
Hear from Ryan Holleran, Strategic Initiatives at Flatiron Health and Basit Chaudhry, CEO and co-founder of Tuple Health about the latest in the Oncology Care First Model (OCF). In this webinar, you will achieve understanding of OCF fundamentals, hear feedback to date, learn about implications for providers, and learn how to prepare for the OCF.
Medicare’s innovation center, the Center for Medicare and Medicaid Innovation (CMMI), can achieve its mission by testing new ways to pay for and deliver healthcare (called Medicare Demonstration projects) that result in:
After five years, the Centers for Medicare and Medicaid Services (CMS) is finally phasing in its approach for controlling advanced diagnostic imaging utilization through the Appropriate Use Criteria Program (AUC).